Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Board changes

22 Dec 2010 07:00

RNS Number : 4068Y
Arden Partners plc
22 December 2010
 

Arden Partners plc

Board changes

 

Arden Partners plc ("Arden" or the "Company") is pleased to announce the appointment of Mark Ansell and Peter Moon as Independent Non-Executive Directors with effect from 31st December 2010 and subject to FSA Regulatory approval.

 

Mark Ansell is a Chartered Accountant and has significant experience as a business consultant and director involved in strategic and corporate finance advice and in management and leadership roles. Mark has held previously senior roles in many organisations including being the Deputy Chief Executive and Finance Director of Aston Villa plc, Interim Chief Executive of Marketing Birmingham and a Senior Partner and Partner in charge of Corporate Finance of Deloitte in Birmingham and the Midlands. Mark will assume the role as Chairman of the Audit Committee. Further disclosures relating to Mark are set out below.

 

Peter Moon has been involved in the institutional investment business for many years. In 2009 Peter retired from the Universities Superannuation Scheme Limited where he was Chief Investment Officer running a fund of some £27.5 billion. The previous institutions where Peter has worked include British Airways Pensions, National Provident and Slater Walker Investment Management. Peter has also acted as adviser to a number of Councils including Lincolnshire and Middlesbrough. He has served as Chairman of the NAPF Stock Exchange Sub-Committee and as a member of the NAPF Investment Committee.

 

The Board of Arden is also pleased to announce, with immediate effect, the appointment of Steve Wassell, the Company's Chief Operating Officer as an Executive Director.

 

The Company also announces the retirement of Tony Bartlett with effect from 31st December 2010. Tony has been involved with Arden since the early days of its inception in 2002 and has played an important role in its development and has carried out many roles for the Company including Chief Executive Officer, Chairman of Corporate Finance and since 2008 as a non-executive director. The Board wishes to thank Tony for his significant contribution to Arden and wishes him well in his retirement.

 

Enquiries:

 

Arden Partners plc

020 7614 5900

Jonathan Keeling - Chief Executive Officer

Trevor Norris - Group Finance Director

 

 

 

Altium 

020 7484 4040

Phil Adams

 

Sam Fuller

 

 

 

Buchanan Communications

020 7466 5000

Mark Edwards

 

Further information

Mark Ansell

Save as set out below, Mark John Ansell (58) has confirmed that there is nothing further to disclose in relation to his appointment to the Board of Arden under Schedule 2, paragraph (g) of the AIM rules for Companies.

 

Details of all companies and partnerships of which Mark Ansell is or has been a director or partner at any time during the past five years:

Current

Past

Amorartis Limited

Chase Midland plc (administration April 2008)

De Montfort Fine Art Limited

 

Mark Ansell Consulting Limited

 

Player Data Analysis Limited

 

RG Parkside Limited

 

Scout7 EBT Limited

 

Scout7 Holdings Limited

 

Scout7 Limited

 

Team Academy Pro Limited

 

Venture 7 Limited

 

Whitewall Galleries Limited

 

 

Peter Moon

Save as set out below, Peter Geoffrey Moon (61) has confirmed that there is nothing further to disclose in relation to his appointment to the Board of Arden under Schedule 2, paragraph (g) of the AIM rules for Companies.

 

Details of all companies and partnerships of which Peter Moon is or has been a director or partner at any time during the past five years:

Current

Past

First Property Group PLC

First Property General Partner Limited

The Scottish American Investment Company PLC

MBNA Europe Bank Limited

 

Universities Investment Management Limited

 

USS Asset Management Limited

 

USS Investment Management Limited

 

 

 

Steve Wassell

Save as set out below, Stephen Michael Wassell (51) has confirmed that there is nothing further to disclose in relation to his appointment to the Board of Arden under Schedule 2, paragraph (g) of the AIM rules for Companies.

 

Details of all companies and partnerships of which Stephen Wassell is or has been a director or partner at any time during the past five years:

Current

Past

None

None

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUARKRRKAUUAA
Date   Source Headline
11th Mar 202112:30 pmRNSDirector/PDMR Shareholding
11th Mar 202110:55 amRNSHolding(s) in Company
3rd Mar 20218:53 amRNSShare Purchase By Employee Benefit Trust
2nd Mar 20214:11 pmRNSGrant of Options
2nd Mar 202110:21 amRNSShare Purchase by Employee Benefit Trust
18th Feb 20213:38 pmRNSPublication of Annual Report and Notice of AGM
17th Feb 202110:55 amRNSShare Purchase By Employee Benefit Trust
16th Feb 20217:00 amRNSAudited Results For The Year Ended 31 October 2020
11th Feb 20211:17 pmRNSDirector/PDMR Shareholding
12th Jan 20212:27 pmRNSDirector/PDMR Shareholding
11th Dec 202012:54 pmRNSDirector/PDMR Shareholding
11th Nov 20203:13 pmRNSTransaction in Own Shares
27th Oct 20209:43 amRNSShare Purchase by Employee Benefit Trust
13th Oct 202010:39 amRNSDirector/PDMR Shareholding
8th Oct 20209:43 amRNSShare Purchase by Employee Benefit Trust
17th Sep 202011:25 amRNSShare Purchase by Employee Benefit Trust
11th Sep 20208:43 amRNSDirector/PDMR Shareholding
7th Sep 202011:04 amRNSShare Purchase by Employee Benefit Trust
4th Sep 202011:57 amRNSShare Purchase by Employee Benefit Trust
11th Aug 20203:43 pmRNSDirector/PDMR Shareholding
11th Aug 20209:15 amRNSShare Purchase by Employee Benefit Trust
29th Jul 20209:05 amRNSShare Purchase by EBT and Holdings in Company
27th Jul 20207:00 amRNSInterim Results - Six Months Ended 30th April 2020
14th Jul 20209:56 amRNSDirector/PDMR Shareholding
9th Jul 20208:38 amRNSHolding(s) in Company
26th Jun 20209:08 amRNSShare Purchase By Employee Benefit Trust
11th Jun 20203:31 pmRNSDirector/PDMR Shareholding
11th Jun 20209:02 amRNSShare Purchase by Employee Benefit Trust
26th May 202011:00 amRNSHolding(s) in Company
26th May 202011:00 amRNSHolding(s) in Company
26th May 202010:58 amRNSDirector/PDMR Shareholding
26th May 20207:00 amRNSEmployee Incentivisation
21st May 20209:50 amRNSShare Purchase by Employee Benefit Trust
19th May 20207:00 amRNSHolding(s) in Company
12th May 20201:36 pmRNSDirector/PDMR Shareholding
1st May 20207:00 amRNSTrading Update
24th Apr 202010:28 amRNSHolding(s) in Company
15th Apr 202012:24 pmRNSDirector/PDMR Shareholding
8th Apr 20208:43 amRNSHolding(s) in Company
30th Mar 202011:55 amRNSForm 8.5 (EPT/NON-RI)
25th Mar 20202:39 pmRNSResult of AGM
20th Mar 20207:00 amRNSStatement Re AGM and Change of Venue
19th Mar 20207:00 amRNSStatement Regarding Share Price Movement
11th Mar 20201:19 pmRNSDirector/PDMR Shareholding
18th Feb 20202:26 pmRNSPublication of Annual Report and Notice of AGM
11th Feb 20202:10 pmRNSDirector/PDMR Shareholding
3rd Feb 20207:00 amRNSPreliminary Results - Year Ended 31 October 2019
13th Jan 20201:51 pmRNSDirector/PDMR Shareholding
2nd Jan 202011:55 amRNSForm 8.5 (EPT/NON-RI)
31st Dec 201911:00 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.